Tumors promote altered maturation and early apoptosis of monocyte-derived dendritic cells

被引:192
作者
Kiertscher, SM
Luo, J
Dubinett, SM
Roth, MD
机构
[1] Univ Calif Los Angeles, Sch Med, Div Pulm & Crit Care Med, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA
[3] W Los Angeles Vet Affairs Med Ctr, Los Angeles, CA 90073 USA
关键词
D O I
10.4049/jimmunol.164.3.1269
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Tumors produce a number of immunosuppressive factors that block the maturation of CD34(+) stem cells into dendritic cells (DC), We hypothesized that tumors might also interfere with the maturation and/or function of human monocyte-derived DC. In contrast to stem cells, we found that CD14(+) cells responded to tumor culture supernatant (TSN) by increasing expression of APC surface markers, up-regulating nuclear translocation of RelB, and developing allostimulatory activity. Although displaying these characteristics of mature DC, TSN-exposed DC lacked the capacity to produce IL-12, did not acquire full allostimulatory activity, and rapidly underwent apoptosis. The effects of TSN appeared to be specific for maturing DC, and were not reversed by Abs against known DC regulatory factors including IL-10, vascular endothelial growth factor, TGF-beta, or PGE(2). Supernatants collected from nonmalignant cell sources had no effect on DC maturation. The altered maturation and early apoptosis of monocyte-derived DC may represent another mechanism by which tumors evade immune detection.
引用
收藏
页码:1269 / 1276
页数:8
相关论文
共 52 条
[1]   Cellular environments and apoptosis: Tissue microenvironments control activated T-cell death [J].
Akbar, AN ;
Salmon, M .
IMMUNOLOGY TODAY, 1997, 18 (02) :72-76
[2]  
Allavena P, 1998, EUR J IMMUNOL, V28, P359, DOI 10.1002/(SICI)1521-4141(199801)28:01<359::AID-IMMU359>3.0.CO
[3]  
2-4
[4]  
Amirkhosravi A, 1998, THROMB HAEMOSTASIS, V80, P598
[5]  
Antonia SJ, 1998, CRIT REV ONCOGENESIS, V9, P35
[6]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[7]  
Botti C, 1998, INT J BIOL MARKER, V13, P51
[8]   Human dendritic cell responses to lipopolysaccharide and CD40 ligation are differentially regulated by interleukin-10 [J].
Buelens, C ;
Verhasselt, V ;
DeGroote, D ;
Thielemans, K ;
Goldman, M ;
Willems, F .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (08) :1848-1852
[9]   ACTIVATION OF HUMAN DENDRITIC CELLS THROUGH CD40 CROSS-LINKING [J].
CAUX, C ;
MASSACRIER, C ;
VANBERVLIET, B ;
DUBOIS, B ;
VANKOOTEN, C ;
DURAND, I ;
BANCHEREAU, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) :1263-1272
[10]   Origin, maturation and antigen presenting function of dendritic cells [J].
Cella, M ;
Sallusto, F ;
Lanzavecchia, A .
CURRENT OPINION IN IMMUNOLOGY, 1997, 9 (01) :10-16